Format

Send to

Choose Destination
Neuromuscul Disord. 2006 May;16(5):334-6. Epub 2006 Apr 17.

Marked efficacy of a therapeutic strategy associating prednisone and plasma exchange followed by rituximab in two patients with refractory myopathy associated with antibodies to the signal recognition particle (SRP).

Author information

1
Department of Internal Medicine, Faculty of Medicine, Cochin Hospital, Paris-Descartes University, Assistance Publique-Hôpitaux de Paris, AP-HP, Paris, France.

Abstract

We report two patients with myopathy associated with anti-signal recognition particle Ab, refractory to conventional therapy, who were treated with prednisone and plasma exchange, followed by rituximab. A marked response was observed in both patients, with partial to complete recovery of muscle strength, which was sustained.

PMID:
16616848
DOI:
10.1016/j.nmd.2006.03.002
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center